Valley Wealth Managers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.01M | Sell |
35,962
-2,691
| -7% | -$377K | 0.32% | 67 |
|
|
2025
Q4 | $4.74M | Sell |
38,653
-235
| -0.6% | -$28.6K | 0.3% | 70 |
|
|
2025
Q3 | $4.32M | Buy |
38,888
+80
| +0.2% | +$9.09K | 0.29% | 75 |
|
|
2025
Q2 | $4.3M | Buy |
38,808
+18
| +0% | +$1.92K | 0.31% | 69 |
|
|
2025
Q1 | $4.35M | Sell |
38,790
-1,692
| -4% | -$175K | 0.33% | 65 |
|
|
2024
Q4 | $3.74M | Sell |
40,482
-5,314
| -12% | -$478K | 0.28% | 76 |
|
|
2024
Q3 | $3.84M | Sell |
45,796
-728
| -2% | -$55.5K | 0.28% | 84 |
|
|
2024
Q2 | $3.19M | Sell |
46,524
-3,329
| -7% | -$222K | 0.25% | 95 |
|
|
2024
Q1 | $3.65M | Sell |
49,853
-4,154
| -8% | -$319K | 0.28% | 93 |
|
|
2023
Q4 | $4.38M | Buy |
54,007
+837
| +2% | +$65.1K | 0.34% | 71 |
|
|
2023
Q3 | $3.98M | Sell |
53,170
-1,543
| -3% | -$119K | 0.33% | 75 |
|
|
2023
Q2 | $4.22M | Sell |
54,713
-2,868
| -5% | -$229K | 0.38% | 68 |
|
|
2023
Q1 | $4.78M | Sell |
57,581
-3,698
| -6% | -$306K | 0.43% | 57 |
|
|
2022
Q4 | $5.26M | Sell |
61,279
-1,516
| -2% | -$120K | 0.49% | 49 |
|
|
2022
Q3 | $3.87M | Buy |
62,795
+642
| +1% | +$40.5K | 0.39% | 66 |
|
|
2022
Q2 | $3.84M | Buy |
62,153
+3,963
| +7% | +$245K | 0.36% | 73 |
|
|
2022
Q1 | $3.46M | Buy |
58,190
+5,801
| +11% | +$371K | 0.29% | 87 |
|
|
2021
Q4 | $3.8M | Buy |
52,389
+758
| +1% | +$52.2K | 0.31% | 75 |
|
|
2021
Q3 | $3.61M | Sell |
51,631
-115
| -0.2% | -$8.08K | 0.31% | 76 |
|
|
2021
Q2 | $3.56M | Buy |
51,746
+4,050
| +8% | +$270K | 0.3% | 83 |
|
|
2021
Q1 | $3.08M | Buy |
47,696
+5,535
| +13% | +$357K | 0.28% | 85 |
|
|
2020
Q4 | $2.46M | Buy |
42,161
+4,274
| +11% | +$258K | 0.24% | 88 |
|
|
2020
Q3 | $2.39M | Buy |
37,887
+3,952
| +12% | +$274K | 0.26% | 74 |
|
|
2020
Q2 | $2.61M | Sell |
33,935
-3,380
| -9% | -$259K | 0.29% | 71 |
|
|
2020
Q1 | $2.79M | Sell |
37,315
-542
| -1% | -$37.5K | 0.36% | 59 |
|
|
2019
Q4 | $2.46M | Buy |
37,857
+3,847
| +11% | +$251K | 0.25% | 81 |
|
|
2019
Q3 | $2.16M | Sell |
34,010
-290
| -0.8% | -$19K | 0.23% | 78 |
|
|
2019
Q2 | $2.32M | Buy |
34,300
+5,330
| +18% | +$351K | 0.25% | 70 |
|
|
2019
Q1 | $1.88M | Buy |
28,970
+6,190
| +27% | +$411K | 0.21% | 79 |
|
|
2018
Q4 | $1.43M | Sell |
22,780
-6,660
| -23% | -$466K | 0.19% | 77 |
|
|
2018
Q3 | $2.27M | Buy |
29,440
+2,205
| +8% | +$167K | 0.27% | 52 |
|
|
2018
Q2 | $1.93M | Buy |
27,235
+325
| +1% | +$22.9K | 0.24% | 57 |
|
|
2018
Q1 | $2.03M | Buy |
26,910
+930
| +4% | +$73.9K | 0.25% | 55 |
|
|
2017
Q4 | $1.86M | Buy |
25,980
+610
| +2% | +$46.3K | 0.22% | 65 |
|
|
2017
Q3 | $2.06M | Buy |
25,370
+2,260
| +10% | +$173K | 0.26% | 56 |
|
|
2017
Q2 | $1.64M | Sell |
23,110
-2,203
| -9% | -$147K | 0.22% | 67 |
|
|
2017
Q1 | $1.72M | Sell |
25,313
-1,263
| -5% | -$88.8K | 0.23% | 66 |
|
|
2016
Q4 | $1.9M | Buy |
26,576
+1,518
| +6% | +$113K | 0.27% | 55 |
|
|
2016
Q3 | $1.98M | Buy |
25,058
+5,175
| +26% | +$420K | 0.29% | 54 |
|
|
2016
Q2 | $1.66M | Buy |
19,883
+17,365
| +690% | +$1.54M | 0.25% | 60 |
|
|
2016
Q1 | $231K | Buy |
2,518
+75
| +3% | +$6.76K | 0.04% | 107 |
|
|
2015
Q4 | $247K | Hold |
2,443
| – | – | 0.04% | 97 |
|
|
2015
Q3 | $240K | Buy |
2,443
+100
| +4% | +$11.1K | 0.04% | 92 |
|
|
2015
Q2 | $274K | Sell |
2,343
-200
| -8% | -$21.9K | 0.05% | 96 |
|
|
2015
Q1 | $250K | Hold |
2,543
| – | – | 0.04% | 99 |
|
|
2014
Q4 | $240K | Buy |
2,543
+103
| +4% | +$10.7K | 0.04% | 101 |
|
|
2014
Q3 | $260K | Buy |
+2,440
| New | +$239K | 0.05% | 97 |
|
Other funds holding GILD
VCM
VPM
Valley Wealth Managers's GILD Position: Q1 2026 in Review
Valley Wealth Managers reduced its Gilead Sciences (GILD) stake by 7% in Q1 2026, selling an estimated $377K and leaving 35,962 shares worth $5.01M. The position accounts for 0.32% of the portfolio, ranked #67.
Valley Wealth Managers first reported a position in GILD in Q3 2014 and has held it in 47 quarters since. The position peaked at $5.26M in Q4 2022. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Valley Wealth Managers held 35,962 shares of Gilead Sciences worth $5.01M as of Q1 2026.
- Valley Wealth Managers sold 2,691 Gilead Sciences shares in Q1 2026, an estimated $377K.
- Gilead Sciences made up 0.32% of Valley Wealth Managers's portfolio in Q1 2026, its #67 holding.
- Valley Wealth Managers first reported a position in Gilead Sciences in Q3 2014 and has held it in 47 quarters since.
- Valley Wealth Managers's Gilead Sciences position peaked at $5.26M in Q4 2022.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Valley Wealth Managers's 13F filing for Q1 2026, filed 6 May 2026.